Intranasal Drug Delivery Market to Reflect Impressive Expansion During 2015-2021
Request Sample Report@ https://www.persistencemarketresearch.com/samples/3631
North America dominates the global market for intranasal drug delivery due to increasing adoption of nasal mode for delivering of drug and improved healthcare facilities in the region. In addition, government initiatives and more awareness among the people are some of the major factors driving the intranasal drug delivery market. Asia, followed by Europe, is expected to experience high growth rate in the next few years in intranasal drug delivery market. China and India are expected to be the fastest growing intranasal drug delivery markets in Asian region. This is due to large investment by various major companies in these countries. Some of the key driving forces for intranasal drug delivery market in emerging countries are large pool of patients, rising government funding and improvement in the healthcare facilities.
Some of the major factors driving the global intranasal drug delivery market are high prevalence of cardiovascular diseases, cancer and diabetes, rising demand for home healthcare devices and increased focus on pediatric and elderly patients. Some other factors driving the global intranasal drug delivery market are improvement in economy of emerging countries, improved healthcare infrastructure. In addition, improvement in the reimbursement scenario is driving the global market for intranasal drug delivery. However, high cost involved and lack of skilled medical professionals are some of the major factors restraining the global market for intranasal drug delivery.
Request TOC@ https://www.persistencemarketresearch.com/methodology/3631
Growing demographics and economies in the developing countries such as India and China are expected to offer good opportunities for the global market for intranasal drug delivery. In addition, increasing R&D for rapid research and development of new drug delivery technologies and devices with better efficacy is expected to offer good opportunities for the global market for intranasal drug delivery. However, failure in drug formulation and technical barriers are some of the major challenge faced by the global market for intranasal drug delivery. One of the latest trends that have been observed in the global intranasal drug delivery market includes companies involved in product launches. Some of the major companies dealing in global intranasal drug delivery market are Aegis Therapeutics LLC, Alza Corporation, AstraZeneca PLC., MedImmune, Inc., Baxter International, Inc., Becton, Dickinson and Company, GlaxoSmithKline PLC and Johnson & Johnson, Inc. some other companies having significant presence in global intranasal drug delivery market are Marina Biotech, Inc., Merck & Co., Novartis AG, Pfizer Inc., Valeant Pharmaceuticals International, Inc. and Rexam Plc.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intranasal Drug Delivery Market to Reflect Impressive Expansion During 2015-2021 here
News-ID: 1337930 • Views: 117
More Releases from Persistence Market Research
Explore Sickle Cell Disease Treatment Market Set to Achieve CAGR 6.0 % in Reven …
Global sickle cell disease treatment market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing adoption of therapies, growing awareness regarding the sickle cell disease treatment in MEA region. “Sickle Cell Disease Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)” is the new report published by Persistence Market Research for the projected period of 8-years, i.e. 2017-2025. According
Gardening Tools Market to Witness CAGR of 1.6% Rise in Value Share During the Pe …
In terms of volume, the global gardening tools market is projected to register 1.6% CAGR during the forecast period 2017 to 2025, according to a recent report by Persistence Market Research (PMR). PMR’s report estimates the global sales of gardening tools to expand from nearly 280,000 ‘000 units in 2017 to surpass 300,000 ‘000 units by 2025-end. People in developed economies consider home improvement and small maintenance activities as a favorable
Industrial Gloves Market to Record CAGR of 9.2% Increase in Revenue by 2025
Persistence Market Research in its new report projects that in 2017, around 113,272 Mn pairs of industrial gloves will be sold worldwide. As per the estimate, hand injuries are among the leading work accidents, hence regulatory bodies are trying to enforce strict worker safety regulations making industrial gloves a compulsory safety gear. According to the report, the global industrial gloves market is set to increase at a CAGR of 9.2%
Crisis Emergency And Incident Management Platforms Market: Where is the Market H …
Every year, the world suffers billions of dollars in economic losses entailing natural calamities or premeditated incidents. Governments from all parts of the world are keeping sizeable wealth as a reserve for dealing with aftermath of such emergency situations. Reimbursing millions among families who lost their members and controlling the property damage by extending redevelopment budgets sounds reasonable, but needs to be carried out effectively. In situations when every penny
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning